Ultragenyx Pharmaceutical
Ultragenyx is a biopharmaceutical company committed to bringing novel therapies to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved medicines and treatment candidates aimed at addressing diseases with high unmet medical need and clear biology, for which there are typically no approved therapies treating the underlying disease.The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Content by Ultragenyx Pharmaceutical
| 5 min read
Transpher A data show a 23.5-point cognitive advantage over natural history, supporting the first-ever FDA approval for pediatric patients with MPS IIIA
Page 1 of 1 - 1 Total Items
